Which Injectable Medication Should I Take for Relapsing-Remitting Multiple Sclerosis? A Decision Aid to Discuss Options With Your Doctor
Loading...
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Which Injectable Medication Should I Take for Relapsing-Remitting Multiple Sclerosis? A Decision Aid to Discuss Options With Your Doctor
Published Date
2016
Publisher
Type
Learning Object
Abstract
Keywords
Description
A literature review for injectable medications used to treat multiple sclerosis was conducted, specifically targeting two groups of injectable medications: beta-interferon and glatiramer acetate. The Ottawa Hospital Research Institute decision aid methodology was applied to create a patient decision aid for the currently available injectable medications. The benefits and risks of the classes of injectable medications are represented visually. The DA was written at a tenth-grade reading level, and a test of decision comfort (SURE test) was incorporated. Patient education experts, patients, and MS specialists were consulted at various institutions (Hennepin County Medical Center’s Center for Patient and Provider Experience, Mayo Clinic’s Shared Decision Making National Resource Center, a patient panel for chronic disease at the Mayo Clinic, and two local MS physicians). Iterative revisions were done based on feedback from each subject matter expert. The final DA is accessible at the University of Minnesota Digital Conservancy and made available for testing in the clinical setting and for future trials.
Related to
Replaces
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Colligan, Erica A; Metzler, Abby; Tiryaki, Ezgi. (2016). Which Injectable Medication Should I Take for Relapsing-Remitting Multiple Sclerosis? A Decision Aid to Discuss Options With Your Doctor. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/181034.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.